×
Progyny EBIT 2018-2025 | PGNY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Progyny ebit from 2018 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
Progyny EBIT 2018-2025 | PGNY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Progyny ebit from 2018 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$135.9B
CVS Health (CVS)
$77.3B
Elevance Health (ELV)
$63.4B
Cencora (COR)
$56.8B
DiDi Global (DIDIY)
$26.5B
Labcorp Holdings (LH)
$21.1B
Natera (NTRA)
$19.1B
BioMerieux (BMXMF)
$16B
EUROFINS SCIENT (ERFSF)
$14.4B
Medpace Holdings (MEDP)
$13.7B
CochLear (CHEOY)
$13.1B
ICON (ICLR)
$13B
Solventum (SOLV)
$12.6B
Revvity (RVTY)
$11.3B
Viatris (VTRS)
$10.8B
Sonic Healthcare (SKHHY)
$9B
Avantor (AVTR)
$8.9B
HealthEquity (HQY)
$8.4B
Charles River Laboratories (CRL)
$8B
Caris Life Sciences,�Inc (CAI)
$7.7B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$5.1B
BrightSpring Health Services (BTSG)
$3.5B
Sotera Health (SHC)
$3.2B
Surgery Partners (SGRY)
$2.8B
Organon (OGN)
$2.6B
Concentras Parent (CON)
$2.5B
Alignment Healthcare (ALHC)
$2.4B
GeneDx Holdings (WGS)
$2.3B
GoodRx Holdings (GDRX)
$1.8B